Putative dopamine agonist (KB220Z) attenuates lucid nightmares in PTSD patients: role of enhanced brain reward functional connectivity and homeostasis redeeming joy.
J Behav Addict June 1, 2015 DOI: 10.1556/2006.4.2015.008 (opens in new tab) via PubMed Central
Summary
AI-generated from the abstractA putative dopamine agonist, KB220Z, reduces lucid nightmares in PTSD patients. The effect is linked to enhanced brain reward functional connectivity and restored homeostasis, which the authors describe as redeeming joy.
Study at a glance
| Characteristics | Observational cohort Peer reviewed |
|---|---|
| Population | PTSD patients |
| Intervention | KB220Z |
| Key finding | KB220Z attenuates lucid nightmares in PTSD patients, associated with enhanced brain reward functional connectivity and homeostasis. |
Abstract
Putative dopamine agonist (KB220Z) attenuates lucid nightmares in PTSD patients: role of enhanced brain reward functional connectivity and homeostasis redeeming joy.